Skip to content
PipDig
EUR/USDLoading…GBP/USDLoading…USD/JPYLoading…XAU/USDLoading…BTC/USDLoading…

Forex News

Quest PharmaTech names Jeffrey Shon CEO, effective Nov. 23

Quest PharmaTech Inc. said Dr. Madi Madiyalakan will retire and Mr. Jeffrey Shon will become CEO on November 23, 2026.

By Fiona McAllister, Global Markets EditorPipDig Newsroom
  • Quest PharmaTech said Dr. Madi Madiyalakan will retire.
  • Mr. Jeffrey Shon will become CEO on November 23, 2026.
  • Quest PharmaTech said its AGM will be held on November 23, 2026, at its corporate offices in Edmonton.
  • Quest PharmaTech said it holds a 26.6% ownership interest in OQPBIOM Inc..

Leadership change

Quest PharmaTech said Dr. Madi Madiyalakan will retire on November 23, 2026. Mr. Jeffrey Shon will become chief executive on the same date.

Top-down view of unlabelled pharmaceutical materials — clear glass vials, a metal syringe barrel and plain blister packs — grouped in the upper two-thirds of a wooden table under soft natural light, with the lower third left empty and calm.
Quest PharmaTech names Jeffrey Shon CEO, effective Nov. 23

Meeting details

The company said its annual general meeting is set for November 23, 2026. It said the meeting will be at its corporate offices in Edmonton.

Holding

Quest PharmaTech said it owns 26.6% of OQPBIOM Inc..

Source: GlobeNewswire,